Terms: = Liver cancer AND SYK, P43405, 6850, ENSG00000165025 AND Clinical Outcome
2 results:
1. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
Apostolidis SA; Sarkar A; Giannini HM; Goel RR; Mathew D; Suzuki A; Baxter AE; Greenplate AR; Alanio C; Abdel-Hakeem M; Oldridge DA; Giles JR; Wu JE; Chen Z; Huang YJ; Belman J; Pattekar A; Manne S; Kuthuru O; Dougherty J; Weiderhold B; Weisman AR; Ittner CAG; Gouma S; Dunbar D; Frank I; Huang AC; Vella LA; ; Reilly JP; Hensley SE; Rauova L; Zhao L; Meyer NJ; Poncz M; Abrams CS; Wherry EJ
Front Immunol; 2022; 13():834988. PubMed ID: 35309299
[TBL] [Abstract] [Full Text] [Related]
2. CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
Hong J; Hu K; Yuan Y; Sang Y; Bu Q; Chen G; Yang L; Li B; Huang P; Chen D; Liang Y; Zhang R; Pan J; Zeng YX; Kang T
J Clin Invest; 2012 Jun; 122(6):2165-75. PubMed ID: 22585575
[TBL] [Abstract] [Full Text] [Related]